Pulmonary/Respiratory Medicine CME

Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Reducing the Burden of Influenza on Children: An Exploration of Novel and Emerging Antiviral Therapy
Jesse Papenburg, MD, MSc, FRCPC
October 8, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Differential Diagnosis of Interstitial Lung Diseases: Interpreting HRCT Accurately and Working With a Multidisciplinary Approach
August 21, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat – Contemporary Insights on Diagnosing and Managing SSc-ILD in an Evolving Treatment Landscape
Lisa H. Lancaster, MD
August 19, 2020
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Building on Progress to Further Advance Care for Patients With EGFR Mutation–Positive NSCLC: A Look at Emerging Precision Medicine Strategies Encompassing Acquired Resistance, Treatment Sequencing, and Patient Considerations
Edward Garon, MD, MS
August 10, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Moving in Leaps and Bounds Toward Expanded Precision Treatment of HER2- or HER3-Driven Breast, Gastrointestinal, Lung, and Other Cancers: Current Challenges, Opportunities for Improvement, and Practical Considerations
Erika Hamilton, MD
August 6, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Finding the Path to Improved Outcomes in Uncontrolled Persistent Asthma: Applying the Latest Clinical Evidence for Treatment Success
Cedric "Jamie" Rutland, MD
July 28, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Coronavirus Disease 2019 (COVID-19): Need-to-Know Information and Practical Guidance for Healthcare Professionals on the Front Lines of Patient Care
Paul E. Sax, MD
July 24, 2020
Credits: 1.00 CME / MOC / CC / CNE / CPE
Medical Learning Institute, Inc.
It's Precisely the Time for More Precision in Genomic Testing and Targeted Treatment of NSCLC
Rebecca S. Heist, MD, MPH
July 23, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
July 14, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 25, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes for Patients With Nontuberculous Mycobacterial Lung Disease: Navigating the Complexities of Diagnosis and Management
Kevin Winthrop, MD, MPH
June 23, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take: Everything You Need to Know About Biomarkers, Immunotherapies, Combinations, and Other Emerging Approaches for Lung Cancer
Suresh S. Ramalingam, MD, FACP, FASCO
June 15, 2020
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Chair's Take on Immunotherapy as a Component of Multimodal Therapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team
Brendon Stiles, MD
June 10, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency
Robin Lachmann, MD, PhD / Melissa Wasserstein, MD
June 3, 2020
Credits: 1.00 CME / MOC / CC / CNE
Medical Learning Institute, Inc.
Improving Outcomes in Patients With Molecularly Altered NSCLC Through Broad Implementation of Precision Testing and Treatment: Latest Evidence and Practical Guidance in the Context of a Changing Targeted Therapy Landscape
Alexander Drilon, MD
April 30, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Overcoming Challenges in the Treatment of Influenza: Examining the Underuse of Antiviral Therapies and Exploring Novel Approaches
Michael G. Ison, MD, MS, FIDSA, FAST
March 26, 2020
Credits: 0.75 CME
National Jewish Health
The Evolving Landscape of Severe Asthma Management: Selecting Patients for Novel Treatment and Improving Adherence
Michael E. Wechsler, MD
March 6, 2020
Credits: 1.00 CME
Purdue University College of Pharmacy
Overcoming Challenges Associated With the Diagnosis and Management of EGPA: An Exploration of Novel Approaches
Praveen Akuthota, MD
February 18, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in Uncontrolled Moderate-to-Severe Asthma: Choosing the Right Treatment for the Right Patient
Reynold A. Panettieri, Jr., MD
December 27, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Recognizing and Managing Progressive Fibrosing ILD in Patients With Connective Tissue Diseases: Examining the Potential Clinical Implications of Antifibrotic Therapy
Lorinda Chung, MD, MS
December 10, 2019
Credits: 1.00 CME
Penn State College of Medicine
Winning Strategies for Diagnosing and Managing Chronic Obstructive Pulmonary Disease
Fernando J. Martinez, MD, MS
November 29, 2019
Credits: 1.00 CME
Penn State College of Medicine
Living With Severe Asthma: Understanding the Patient Experience to Guide Therapeutic Decision-Making
Nicola A. Hanania, MD, MS
November 29, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes
Kathryn Beal, MD / Sandip Patel, MD
November 4, 2019
Credits: 1.50 CME
Purdue University College of Pharmacy
Teaming Up to Overcome Challenges in Severe Asthma Management: The Role of Targeted Therapy in Personalized Care
William J. Calhoun, MD / Neil S. Skolnik, MD
October 30, 2019
Medical Learning Institute, Inc.
Improving the Diagnosis, Treatment, and Outcomes of Patients With HAP and VAP: A Critical Look at Current Guidelines and New Treatment Options
Andrew F. Shorr, MD, MPH, MBA, FACP, FCCP
October 17, 2019
Medical Learning Institute, Inc.
Applying New Insights to Improve Diagnosis and Management of Interstitial Lung Diseases
Amy L. Olson, MD, MSPH
August 1, 2019
Medical Learning Institute, Inc.
Expanding Treatment Choices in Mesothelioma: Exploring the Promise of Tumor Treating Fields and Novel Systemic Approaches to Optimize Patient Outcomes
Charles B. Simone, MD, FACRO
July 29, 2019
Medical Learning Institute, Inc.
Expanding Options and Difficult Choices in the Initial Treatment of Advanced NSCLC: How to Personalize Treatment Decisions in the Era of Immuno-Oncology and Combinations
Mark A. Socinski, MD
March 27, 2019